VARIAN MEDICAL SYSTEMS UK HOLDINGS LIMITED

Varian Medical Systems UK Holdings Limited specialises in remote-afterloading brachytherapy systems. These devices are engineered to deliver precise radiation therapy directly to targeted areas, commonly used in cancer treatment. The focus is on advanced radiation delivery solutions, ensuring accuracy and minimising exposure to surrounding healthy tissue.

The company is headquartered in the United States. While the UK Holdings Limited entity may have local operations or subsidiaries, the primary corporate base and regulatory oversight align with the US jurisdiction.

Varian’s devices, such as the VariSource iX and VariSource iX(t), are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency in the medical device supply chain, allowing healthcare providers, regulators, and patients to verify device details, compliance, and recall information when needed.

Varian’s remote-afterloading brachytherapy systems are classified as Class II devices. This classification typically applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as performance standards, post-market surveillance, or patient monitoring requirements.